ly3457263
Showing 1 - 3 of 3
Overweight, Obesity Trial in Daytona Beach (LY3457263, Tirzepatide, Placebo)
Recruiting
- Overweight
- Obesity
- LY3457263
- +2 more
-
Daytona Beach, FloridaLabCorp CRU, Inc.
Dec 8, 2022
Diabetes, Type 2 Trial in United States (LY3457263, Placebo, Dulaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- LY3457263
- +2 more
-
Anniston, Alabama
- +4 more
Dec 8, 2022
Healthy, Type 2 Diabetes Trial in Neuss, Mainz (LY3457263, Dulaglutide, Placebo)
Completed
- Healthy
- Type 2 Diabetes
- LY3457263
- +2 more
-
Neuss, Nordrhein-Westfalen, Germany
- +1 more
Jan 10, 2022